周五盘前，医疗器械公司Globus Medical（股票代码：GMED）股价大幅上涨29.38%，引发市场广泛关注。这一显著涨幅主要源于多家知名券商对该公司股票评级的上调。
据悉，杰富瑞证券将Globus Medical的目标价从88美元大幅上调至105美元，上调幅度达到19.3%。同时，加拿大皇家银行也将其目标价从88美元提高到92美元。更值得注意的是，Truist Securities将Globus Medical的评级从"持有"上调至"买入"，并将目标价从65美元大幅上调至93美元，上调幅度高达43%。
Globus Medical是一家专注于脊柱和骨科解决方案的医疗技术公司。这些积极的分析师评级变化表明，华尔街对公司未来的业务前景和增长潜力持乐观态度。投资者似乎对这些利好消息反应强烈，推动了股价的大幅上涨。然而，投资者在做出投资决策时仍需谨慎，综合考虑公司基本面、行业趋势和整体市场环境等多方面因素。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.